Todos Medical Ltd.
TOMDF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.04 | 0.01 | 0.01 |
| FCF Yield | 6.97% | 2.55% | -6.34% | -10.35% |
| EV / EBITDA | -27.10 | -27.00 | -20.61 | -50.30 |
| Quality | ||||
| ROIC | -51.21% | -31.22% | -30.57% | -58.41% |
| Gross Margin | 100.00% | 33.44% | 53.02% | 40.10% |
| Cash Conversion Ratio | 0.16 | -0.11 | 0.18 | 0.17 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.90% | 101.39% | 575.08% | 2,110,204.61% |
| Free Cash Flow Growth | 52.40% | 156.92% | 32.38% | 26.74% |
| Safety | ||||
| Net Debt / EBITDA | -20.35 | -16.50 | -14.17 | -34.18 |
| Interest Coverage | -0.66 | -0.53 | -0.44 | -0.55 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.97 | 0.67 | 0.80 |
| Cash Conversion Cycle | 67.23 | -166.24 | -110.32 | -52.45 |